Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New adjunctive therapy for ischemic syndromes.

M J De Jong1, S L Wright

  • 1Cardiovascular Intensive Care Unit, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Texas, USA. mdejong@aol.com

Critical Care Nursing Clinics of North America
|April 29, 2000
PubMed
Summary

Anticoagulant and GP IIb/IIIa inhibitors are standard care for unstable angina (USA) and non-ST elevation myocardial infarction (NSTEMI), reducing mortality and complications. Further research is needed on optimal use and long-term benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare professionals' perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaire.

BMC geriatrics·2026
Same author

Examining the release of synthetic microfibres to the environment via two major pathways: Atmospheric deposition and treated wastewater effluent.

The Science of the total environment·2022
Same author

Atmospheric microplastic deposition in an urban environment and an evaluation of transport.

Environment international·2020
Same author

Distance and direction, but not light cues, support response reversal learning.

Learning & behavior·2018
Same author

The Prevalence of Latent Tuberculosis and Hepatitis B After Systematic Screening of Patients Prescribed Biological Therapy in a Low-endemic Area.

Journal of Crohn's & colitis·2017
Same author

An odd looking man.

The Netherlands journal of medicine·2012

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Anticoagulant and GP IIb/IIIa inhibitors are increasingly used for acute coronary syndromes.
  • These agents have demonstrated significant reductions in mortality and ischemic events.

Purpose of the Study:

  • To review the current standard of care for patients with unstable angina (USA) and non-ST elevation myocardial infarction (NSTEMI).
  • To highlight ongoing research and unanswered questions regarding these pharmacologic agents.

Main Methods:

  • Literature review of clinical trials and guidelines.
  • Synthesis of current evidence on anticoagulant and GP IIb/IIIa inhibitor therapy.

Main Results:

  • These agents are standard of care, reducing mortality, myocardial ischemia, acute myocardial infarction (AMI), and reintervention.

Related Experiment Videos

  • Optimal treatment regimens, dosing, long-term benefits, and cost-effectiveness require further investigation.

    • Conclusions:

    • Anticoagulant and GP IIb/IIIa inhibitors are crucial in managing USA and NSTEMI.
    • Continued research and nursing involvement are vital for advancing ischemic heart disease prevention.